IBI: AP899; Marija Mojić***, naučni saradnik, Univerzitet u Beogradu, Institut za biološka istraživanja 'Siniša Stanković'; Polje: prirodno-matematičke i medicinske nauke; Period: 2018-2024;
eNauka profil: rp07344; ORCID: 0000-0002-4906-9880;
WOS indikatori: NR = 44; TC = 1031; HIndex = 18;
eNauka WOS indikatori: NR = 52; TC = 1029; HIndex = 18 ;
Lista A broj bodova: 57.12205 (618) 33.2%; Lista B broj bodova: 633.243 (618) 0.5%; Lista C broj bodova: 0.000 (0) nan%; Lista A broj bodova kolaboracije: 0.000 (0) nan%; Lista B broj bodova kolaboracije: 0.000 (0) nan%;
Statistika svih rezultata
| Statistika | Ukupno | 2013-2024 | 2015-2024 | 2018-2024 | 2020-2024 |
|---|---|---|---|---|---|
| Broj rezultata | 44 | 29 | 19 | 10 | 8 |
| Broj citata | 1031 | 826 | |||
| Broj M bodova | 87.00 | 87 | 82.00 | 67 | |
| Normirani broj citata | 768.14 | 633.24 | |||
| Normirani broj M bodova rezultata kategorije M21a++M21a+M21+M22+M23+M24 | 61.62 | 61.62 | 57.12 | 43.62 | |
| Normirani broj M bodova rezultata kategorije M11+M12+M13+M14+M41 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Normirani broj M bodova rezultata kategorije M11+M12+M13+M14+M41+M42 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Normirani broj M bodova rezultata kategorije M51 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Normirani broj M bodova rezultata kategorije M43+M44 | 0.00 | 0.00 | 0.00 | 0.00 |
Statistika rezultata nastalih u medunarodnim kolaboracijama
| Statistika | Ukupno | 2013-2024 | 2015-2024 | 2018-2024 | 2020-2024 |
|---|---|---|---|---|---|
| Broj rezultata sa 20 i više autora | 0 | 0 | 0 | 0 | 0 |
| Broj citata rezultata sa 20 i više autora | 0 | 0 | |||
| Broj M bodova rezultata M21a++M21a+M21+M22+M23 sa 20 i više autora | 0.00 | 0 | 0.00 | 0 | |
| Normirani broj citata rezultata sa 20 i više autora | 0.00 | 0.00 | |||
| Normirani broj M bodova rezultata M21a++M21a+M21+M22+M23 sa 20 i više autora | 0.00 | 0.00 |
Rezultati
| RB | IBI | Godina | Kat | Tip | Vrsta | Referenca | TC | TCP | BA | NBB | NTC | Naslov | Autori | 1. | AP899 | 2008 | E | NITRIC OXIDE-BIOLOGY AND CHEMISTRY Vol. 19 (2): # 177 - 183 (7), (DOI: 10.1016/j.niox.2008.04.004) SEP 2008WOS | 21 | 6 | 16 | 0 | 2.1429 | Novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide (GIT-27NO) induces p53 mediated apoptosis in human A375 melanoma cells | Mijatovic S, Maksimovic-Ivanic D, Mojic M, Malaponte G, Libra M, Cardile V, Miljkovic D, Harhaji L, Dabideen D, Cheng K, Bevelacqua Y, Donia M, Garotta G, Ai-Abed Y, Stosic-Grujicic S, Nicoletti F | 2. | AP899 | 2009 | E | MOLECULAR CANCER THERAPEUTICS Vol. 8 (5): # 1169 - 1178 (10), (DOI: 10.1158/1535-7163.MCT-08-0998) MAY 2009WOS | 39 | 21 | 15 | 0 | 8.0769 | The antitumor properties of a nontoxic, nitric oxide-modified version of saquinavir are independent of Akt | Maksimovic-Ivanic D, Mijatovic S, Miljkovic D, Harhaji-Trajkovic L, Timotijevic G, Mojic M, Dabideen D, Cheng K, McCubrey J, Mangano K, Al-Abed Y, Libra M, Garotta G, Stosic-Grujicic S, Nicoletti F | 3. | AP899 | 2011 | E | JOURNAL OF CELLULAR PHYSIOLOGY Vol. 226 (7): # 1803 - 1812 (10), (DOI: 10.1002/jcp.22513) JUL 2011WOS | 28 | 16 | 12 | 0 | 8.0000 | Cytotoxic and Immune-Sensitizing Properties of Nitric Oxide-Modified Saquinavir in iNOS-Positive Human Melanoma Cells | Mijatovic S, Maksimovic-Ivanic D, Mojic M, Timotijevic G, Miljkovic D, Mangano K, Donia M, Di C, Al-Abed Y, Cheng K, Stosic-Grujicic S, Nicoletti F | 4. | AP899 | 2011 | E | CANCER RESEARCH Vol. 71 (20): # 6419 - 6427 (9), (DOI: 10.1158/0008-5472.CAN-11-1773) OCT 15 2011WOS | 18 | 12 | 6 | 0 | 12.0000 | Asialoglycoprotein Receptor Promotes Cancer Metastasis by Activating the EGFR-ERK Pathway | Ueno S, Mojic M, Ohashi Y, Higashi N, Hayakawa Y, Irimura T | 5. | AP899 | 2011 | E | CELL CYCLE Vol. 10 (3): # 492 - 499 (8), (DOI: 10.4161/cc.10.3.14727) FEB 1 2011WOS | 40 | 24 | 12 | 0 | 12.0000 | In vitro and in vivo anticancer action of Saquinavir-NO, a novel nitric oxide-derivative of the protease inhibitor saquinavir, on hormone resistant prostate cancer cells | Donia M, Maksimovic-Ivanic D, Mijatovic S, Mojic M, Miljkovic D, Timotijevic G, Fagone P, Caponnetto S, Al-Abed Y, McCubrey J, Stosic-Grujicic S, Nicoletti F | 6. | AP899 | 2012 | E | JOURNAL OF INORGANIC BIOCHEMISTRY Vol. 109 (): # 40 - 48 (9), (DOI: 10.1016/j.jinorgbio.2012.01.012) APR 2012WOS | 28 | 22 | 13 | 0 | 10.0000 | Novel methylene modified cyclohexyl ethylenediamine-N,N′-diacetate ligands and their platinum(IV) complexes. Influence on biological activity | Mihajlovic L, Savic A, Poljarevic J, Vuckovic I, Mojic M, Bulatovic M, Maksimovic-Ivanic D, Mijatovic S, Kaluderovic G, Stosic-Grujicic S, Miljkovic D, Grguric-Sipka S, Sabo T | 7. | AP899 | 2012 | E | METALLOMICS Vol. 4 (9): # 979 - 987 (9), (DOI: 10.1039/c2mt20058a) 2012WOS | 37 | 29 | 12 | 0 | 14.5000 | Platinum(II/IV) complexes containing ethylenediamine-N,N′-di-2/3-propionate ester ligands induced caspase-dependent apoptosis in cisplatin-resistant colon cancer cells | Kaluderovic G, Mijatovic S, Zmejkovski B, Bulatovic M, Gómez-Ruiz S, Mojic M, Steinborn D, Miljkovic D, Schmidt H, Stosic-Grujicic S, Sabo T, Maksimovic-Ivanic D | 8. | AP899 | 2012 | E | MOLECULAR PHARMACOLOGY Vol. 82 (4): # 700 - 710 (11), (DOI: 10.1124/mol.112.077842) OCT 2012WOS | 28 | 21 | 14 | 0 | 8.7500 | Therapeutic Potential of Nitric Oxide-Modified Drugs in Colon Cancer Cells | Mojic M, Mijatovic S, Maksimovic-Ivanic D, Miljkovic D, Stosic-Grujicic S, Stankovic M, Mangano K, Travali S, Donia M, Fagone P, Zocca M, Al-Abed Y, McCubrey J, Nicoletti F | 9. | AP899 | 2012 | E | CELL CYCLE Vol. 11 (6): # 1174 - 1182 (9), (DOI: 10.4161/cc.11.6.19611) MAR 15 2012WOS | 15 | 11 | 14 | 0 | 4.5833 | Saquinavir-NO-targeted S6 protein mediates sensitivity of androgen-dependent prostate cancer cells to TRAIL | Mojic M, Mijatovic S, Maksimovic-Ivanic D, Dinic S, Grdovic N, Miljkovic D, Stosic-Grujicic S, Tumino S, Fagone P, Mangano K, Zocca M, Al-Abed Y, McCubrey J, Nicoletti F | 10. | AP899 | 2013 | E | JOURNAL OF MEMBRANE BIOLOGY Vol. 246 (4): # 307 - 314 (8), (DOI: 10.1007/s00232-013-9531-1) APR 2013WOS | 22 | 18 | 7 | 0 | 18.0000 | Membrane Fluidity, Invasiveness and Dynamic Phenotype of Metastatic Prostate Cancer Cells after Treatment with Soy Isoflavones | Ajdzanovic V, Mojic M, Maksimovic-Ivanic D, Bulatovic M, Mijatovic S, Milosevic V, Spasojevic I | 11. | AP899 | 2013 | E | JOURNAL OF MEDICAL BIOCHEMISTRY Vol. 32 (4): # 406 - 416 (11), (DOI: 10.2478/jomb-2013-0050) OCT 2013WOS | 2 | 2 | 11 | 0 | 1.1111 | NO-MODIFIED SAQUINAVIR IS EQUALLY EFFICIENT AGAINST DOXORUBICIN SENSITIVE AND RESISTANT NON-SMALL CELL LUNG CARCINOMA CELLS | Mijatovic S, Pesic M, Mojic M, Bankovic J, Miljkovic D, Fagone P, Mangano K, Nicoletti F, McCubrey J, Tanic N, Maksimovic-Ivanic D | 12. | AP899 | 2013 | E | DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES Vol. 8 (2): # 877 - U461 (10), (DOI: ) APR-JUN 2013WOS | 3 | 3 | 10 | 0 | 1.8750 | IN VITRO ASSESSMENT OF Ni-Cr AND Co-Cr DENTAL ALLOYS UPON RECASTING: CELLULAR COMPATIBILITY | Cairovic A, Djordjevic I, Bulatovic M, Mojic M, Momcilovic M, Stosic-Grujicic S, Maksimovic V, Maksimovic-Ivanic D, Mijatovic S, Stamenkovic D | 13. | AP899 | 2013 | E | JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY Vol. 64 (3): # 361 - 368 (8), (DOI: ) JUN 2013WOS | 9 | 8 | 7 | 0 | 8.0000 | GENISTEIN AFFECTS PARATHYROID GLAND AND NaPi 2a COTRANSPORTER IN AN ANIMAL MODEL OF THE ANDROPAUSE | Pantelic J, Ajdzanovic V, Medigovic I, Mojic M, Trifunovic S, Milosevic V, Filipovic B | 14. | AP899 | 2014 | E | ANGEWANDTE CHEMIE-INTERNATIONAL EDITION Vol. 53 (23): # 5982 - 5987 (6), (DOI: 10.1002/anie.201400763) JUN 2014WOS | 90 | 84 | 13 | 0 | 38.1818 | Organotin(IV)-Loaded Mesoporous Silica as a Biocompatible Strategy in Cancer Treatment | Bulatovic M, Maksimovic-Ivanic D, Bensing C, Gómez-Ruiz S, Steinborn D, Schmidt H, Mojic M, Korac A, Golic I, Pérez-Quintanilla D, Momcilovic M, Mijatovic S, Kaluderovic G | 15. | AP899 | 2014 | E | JOURNAL OF ORGANOMETALLIC CHEMISTRY Vol. 751 (): # 361 - 367 (7), (DOI: 10.1016/j.jorganchem.2013.07.059) FEB 1 2014WOS | 11 | 9 | 10 | 0 | 5.6250 | Study of the anticancer properties of methyl- and phenyl-substituted carbon- and silicon-bridged ansa-titanocene complexes | Mijatovic S, Bulatovic M, Mojic M, Stosic-Grujicic S, Miljkovic D, Maksimovic-Ivanic D, Gómez-Ruiz S, Pinkas J, Horácek M, Kaluderovic G | 16. | AP899 | 2014 | E | JOURNAL OF ORGANOMETALLIC CHEMISTRY Vol. 749 (): # 142 - 149 (8), (DOI: 10.1016/j.jorganchem.2013.08.041) JAN 1 2014WOS | 9 | 7 | 10 | 0 | 4.3750 | Synthesis, X-ray structure and strong in vitro cytotoxicity of novel organoruthenium complexes | Mojic M, Savic A, Arion V, Bulatovic M, Poljarevic J, Miljkovic D, Sabo T, Mijatovic S, Maksimovic-Ivanic D, Grguric-Sipka S | 17. | AP899 | 2014 | E | SCIENTIFIC REPORTS Vol. 4 (): #5955 - (8), (DOI: 10.1038/srep05955) AUG 5 2014WOS | 56 | 52 | 7 | 0 | 52.0000 | Extracellular iron diminishes anticancer effects of vitamin C: An in vitro study | Mojic M, Pristov J, Maksimovic-Ivanic D, Jones D, Stanic M, Mijatovic S, Spasojevic I | 18. | AP899 | 2014 | E | JOURNAL OF MATERIALS CHEMISTRY B Vol. 2 (21): # 3271 - 3281 (11), (DOI: 10.1039/c4tb00300d) 2014WOS | 13 | 12 | 8 | 0 | 10.0000 | Undecylprodigiosin conjugated monodisperse gold nanoparticles efficiently cause apoptosis in colon cancer cells in vitro | Nikodinovic-Runic J, Mojic M, Kang Y, Maksimovic-Ivanic D, Mijatovic S, Vasiljevic B, Stamenkovic V, Senerovic L | 19. | AP899 | 2014 | E | CELLS TISSUES ORGANS Vol. 200 (3-4): # 265 - 277 (13), (DOI: 10.1159/000434625) 2014WOS | 38 | 37 | 6 | 0 | 37.0000 | A Key Role of Autophagy in Osteoblast Differentiation on Titanium-Based Dental Implants | Kaluderovic M, Mojic M, Schreckenbach J, Maksimovic-Ivanic D, Graf H, Mijatovic S | 20. | AP899 | 2015 | E | APPLIED ORGANOMETALLIC CHEMISTRY Vol. 29 (1): # 20 - 25 (6), (DOI: 10.1002/aoc.3238) JAN 2015WOS | 9 | 8 | 8 | 0 | 6.6667 | Binuclear dichlorido(η6-p-cymene)ruthenium(II) complexes with bis(nicotinate)- and bis (isonicotinate)-polyethylene glycol ester ligands | Eichhorn T, Hey-Hawkins E, Maksimovic-Ivanic D, Mojic M, Schmidt J, Mijatovic S, Schmidt H, Kaluderovic G | 21. | AP899 | 2015 | E | JOURNAL OF MEMBRANE BIOLOGY Vol. 248 (1): # 1 - 6 (6), (DOI: 10.1007/s00232-014-9745-x) FEB 2015WOS | 21 | 20 | 5 | 0 | 20.0000 | Membrane Steroid Receptor-Mediated Action of Soy Isoflavones: Tip of the Iceberg | Ajdzanovic V, Medigovic I, Zivanovic J, Mojic M, Milosevic V | 22. | AP899 | 2015 | E | EUROPEAN JOURNAL OF PHARMACOLOGY Vol. 760 (): # 136 - 144 (9), (DOI: 10.1016/j.ejphar.2015.04.012) AUG 5 2015WOS | 9 | 9 | 10 | 0 | 5.6250 | Improved in vitro antitumor potential of (O,O'-Diisobutyl-ethylenediamine-N,N'-di-3-propionate)tetrachloridoplatinum(IV) complex under normoxic and hypoxic conditions | Bulatovic M, Kaluderovic M, Mojic M, Zmejkovski B, Hey-Hawkins E, Vidakovic M, Grdovic N, Kaluderovic G, Mijatovic S, Maksimovic-Ivanic D | 23. | AP899 | 2015 | E | LEUKEMIA RESEARCH Vol. 39 (10): # 1088 - 1095 (8), (DOI: 10.1016/j.leukres.2015.06.013) OCT 2015WOS | 25 | 25 | 14 | 0 | 10.4167 | The NO-modified HIV protease inhibitor as a valuable drug for hematological malignancies: Role of p70S6K | Maksimovic-Ivanic D, Mojic M, Bulatovic M, Radojkovic M, Kuzmanovic M, Ristic S, Stosic-Grujicic S, Miljkovic D, Cavalli E, Libra M, Fagone P, McCubrey J, Nicoletti F, Mijatovic S | 24. | AP899 | 2016 | E | DALTON TRANSACTIONS Vol. 45 (47): # 18984 - 18993 (10), (DOI: 10.1039/c6dt03519a) DEC 21 2016WOS | 34 | 31 | 8 | 0 | 25.8333 | Evaluation of functionalized mesoporous silica SBA-15 as a carrier system for Ph3Sn(CH2)3OH against the A2780 ovarian carcinoma cell line | Bensing C, Mojic M, Gómez-Ruiz S, Carralero S, Doloinovic B, Maksimovic-Ivanic D, Mijatovic S, Kaluderovic G | 25. | AP899 | 2016 | E | MOLECULAR BIOLOGY Vol. 50 (1): # 153 - 156 (4), (DOI: 10.1134/S002689331601012X) JAN 2016WOS | 3 | 2 | 7 | 0 | 2.0000 | ALPHA-1 Antitrypsin Affects U0126-Induced Cytotoxicity in Colon Cancer Cell Line (HCT116) | Ljujic M, Mijatovic S, Bulatovic M, Mojic M, Maksimovic-Ivanic D, Radojkovic D, Topic A | 26. | AP899 | 2016 | E | ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY Vol. 16 (3): # 359 - 364 (6), (DOI: 10.2174/1871520615666151007160319) 2016WOS | 11 | 11 | 5 | 0 | 11.0000 | Anticancer Activity of Organogallium(III) Complexes in Colon Cancer Cells | Kaluderovic M, Mojic M, Gómez-Ruiz S, Mijatovic S, Maksimovic-Ivanic D | 27. | AP899 | 2016 | E | ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY Vol. 16 (11): # 1455 - 1460 (6), (DOI: 10.2174/1871520615666151029100749) 2016WOS | 10 | 9 | 7 | 0 | 9.0000 | Biological Potential of Halfsandwich Ruthenium(II) and Iridium (III) Complexes | Ludwig G, Mojic M, Bulatovic M, Mijatovic S, Maksimovic-Ivanic D, Steinborn D, Kaluderovic G | 28. | AP899 | 2017 | E | PATHOLOGY & ONCOLOGY RESEARCH Vol. 23 (2): # 335 - 343 (9), (DOI: 10.1007/s12253-016-0104-3) APR 2017WOS | 4 | 4 | 7 | 0 | 4.0000 | Alpha-1-Antitrypsin Antagonizes Cisplatin-Induced Cytotoxicity in Prostate Cancer (PC3) and Melanoma Cancer (A375) Cell Lines | Ljujic M, Mijatovic S, Bulatovic M, Mojic M, Maksimovic-Ivanic D, Radojkovic D, Topic A | 29. | AP899 | 2018 | M21 | E | Review | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES Vol. 19 (1): #89 - (13), (DOI: 10.3390/ijms19010089) JAN 2018WOS | 270 | 231 | 3 | 6.0000 | 231.0000 | The Dark Side of IFN-: Its Role in Promoting Cancer Immunoevasion | Mojic M, Takeda K, Hayakawa Y | 30. | AP899 | 2019 | M21a | E | Article | ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER Vol. 221 (): # 27 - 37 (11), (DOI: 10.1016/j.aanat.2018.08.001) 2019WOS | 12 | 9 | 8 | 7.5000 | 7.5000 | Daidzein upregulates anti-aging protein Klotho and NaPi 2a cotransporter in a rat model of the andropause | Zivanovic J, Jaric I, Ajdzanovic V, Mojic M, Miler M, Sosic-Jurjevic B, Milosevic V, Filipovic B | 31. | AP899 | 2021 | M21a | E | Article | MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS Vol. 124 (): #112078 - (9), (DOI: 10.1016/j.msec.2021.112078) MAY 2021WOS | 50 | 36 | 12 | 6.0000 | 18.0000 | Development of genistein-loaded gold nanoparticles and their antitumor potential against prostate cancer cell lines | Vodnik V, Mojic M, Stamenovic U, Otonicar M, Ajdzanovic V, Maksimovic-Ivanic D, Mijatovic S, Markovic M, Barudzija T, Filipovic B, Milosevic V, Sosic-Jurjevic B | 32. | AP899 | 2021 | M21 | E | Article | CANCER SCIENCE Vol. 112 (9): # 3484 - 3490 (7), (DOI: 10.1111/cas.15050) SEP 2021WOS | 5 | 3 | 9 | 5.7143 | 2.1429 | NKG2D defines tumor-reacting effector CD8+ T cells within tumor microenvironment | Mojic M, Shitaoka K, Ohshima C, Ucche S, Lyu F, Hamana H, Tahara H, Kishi H, Hayakawa Y | 33. | AP899 | 2022 | M21 | E | Article | ACS OMEGA Vol. 7 (28): # 24282 - 24291 (10), (DOI: 10.1021/acsomega.2c01523) JUL 19 2022WOS | 24 | 17 | 10 | 5.0000 | 10.6250 | Carboranyl Analogues of Mefenamic Acid and Their Biological Evaluation | Useini L, Mojic M, Laube M, Loennecke P, Dahme J, Sarosi M, Mijatovic S, Maksimovic-Ivanic D, Pietzsch J, Hey-Hawkins E | 34. | AP899 | 2022 | M23 | E | Article | BIOMATERIALS ADVANCES Vol. 140 (): #213054 - (8), (DOI: 10.1016/j.bioadv.2022.213054) SEP 2022WOS | 5 | 3 | 9 | 2.1429 | 2.1429 | Effect of chain length on the cytotoxic activity of (alkyl-ω-ol)triphenyltin(IV) loaded into SBA-15 nanostructured silica and in vivo study of SBA-15∼Cl|Ph3Sn(CH2)8OH | Bensing C, Mojic M, Bulatovic M, Edeler D, Pérez-Quintanilla D, Gómez-Ruiz S, Maksimovic-Ivanic D, Mijatovic S, Kaluderovic G | 35. | AP899 | 2023 | M21 | E | Article | CHEMMEDCHEM Vol. 18 (5): # - (8), (DOI: 10.1002/cmdc.202200583) MAR 1 2023WOS | 17 | 9 | 8 | 6.6667 | 7.5000 | Carborane Analogues of Fenoprofen Exhibit Improved Antitumor Activity | Useini L, Mojic M, Laube M, Lönnecke P, Mijatovic S, Maksimovic-Ivanic D, Pietzsch J, Hey-Hawkins E | 36. | AP899 | 2023 | M21 | E | Article | MOLECULAR CANCER RESEARCH Vol. 21 (1): # 76 - 85 (10), (DOI: 10.1158/1541-7786.MCR-22-0369) JAN 2023WOS | 2 | 1 | 9 | 5.7143 | 0.7143 | GSTA4 Governs Melanoma Immune Resistance and Metastasis | Ucche S, Yokoyama S, Mojic M, Oki K, Ohshima C, Tsuihiji H, Takasaki I, Tahara H, Hayakawa Y | 37. | AP899 | 2023 | M21 | E | Article | NANOMATERIALS Vol. 13 (3): #372 - (16), (DOI: 10.3390/nano13030372) FEB 2023WOS | 8 | 4 | 9 | 5.7143 | 2.8571 | Melanoma Cell Reprogramming and Awakening of Antitumor Immunity as a Fingerprint of Hyper-Harmonized Hydroxylated Fullerene Water Complex (3HFWC) and Hyperpolarized Light Application In Vivo | Markelic M, Mojic M, Bovan D, Jelaca S, Jovic Z, Puric M, Koruga D, Mijatovic S, Maksimovic-Ivanic D | 38. | AP899 | 2024 | M21a | E | Article | PHARMACEUTICS Vol. 16 (11): #1437 - (20), (DOI: 10.3390/pharmaceutics16111437) NOV 2024WOS | 4 | 0 | 11 | 6.6667 | 0.0000 | A Comprehensive Evaluation of a Coumarin Derivative and Its Corresponding Palladium Complex as Potential Therapeutic Agents in the Treatment of Gynecological Cancers: Synthesis, Characterization, and Cytotoxicity | Jevtic M, Pirkovic M, Komazec T, Mojic M, Mijatovic S, Maksimovic-Ivanic D, Dimic D, Markovic Z, Simijonovic D, Milenkovic D, Avdovic E | 39. | AP899 | 2025 | E | CHEMICO-BIOLOGICAL INTERACTIONS Vol. 418 (): #111561 - (14), (DOI: 10.1016/j.cbi.2025.111561) SEP 5 2025WOS | 0 | 0 | 9 | 0 | 0.0000 | Incorporating alkylthio groups provides potent in vitro anticancer activity to water-soluble and aqueous-stable diiron(I) bis-cyclopentadienyl complexes | Saviozzi C, Mojic M, Biancalana L, Funaioli T, Biver T, Zacchini S, Mijatovic S, Maksimovic-Ivanic D, Marchetti F | 40. | AP899 | 2025 | E | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY Vol. 287 (): #117364 - (18), (DOI: 10.1016/j.ejmech.2025.117364) APR 5 2025WOS | 1 | 0 | 9 | 0 | 0.0000 | Anticancer activity promoted by ligand diversity in diiron thiocarbyne complexes | Mihajlovic E, Biancalana L, Mojic M, Jelaca S, Chiaverini L, Zacchini S, Mijatovic S, Maksimovic-Ivanic D, Marchetti F | 41. | AP899 | 2025 | E | IMMUNOLOGY LETTERS Vol. 276 (): #107051 - (10), (DOI: 10.1016/j.imlet.2025.107051) DEC 2025WOS | 0 | 0 | 6 | 0 | 0.0000 | Innate lymphoid cells: Dual roles and therapeutic opportunities in breast cancer | Mojic M, Radulovic N, Bobic S, Radenkovic S, Cruz-Adalia A, Stojanovic I | 42. | AP899 | 2025 | E | INORGANIC CHEMISTRY FRONTIERS Vol. 12 (24): # 8650 - 8675 (26), (DOI: 10.1039/d5qi01498k) DEC 2 2025WOS | 0 | 0 | 11 | 0 | 0.0000 | A bridging thiocarbyne ligand in diiron(i) complexes enables unconventional isomerization pathways and structural diversity leading to potent cytotoxicity | Biancalana L, Mihajlovic E, Ciancaleoni G, Mojic M, Jelaca S, Zacchini S, Pampaloni G, Dojcinovic B, Maksimovic-Ivanic D, Mijatovic S, Marchetti F | 43. | AP899 | 2025 | E | MOLECULES Vol. 30 (21): #4153 - (20), (DOI: 10.3390/molecules30214153) OCT 22 2025WOS | 0 | 0 | 12 | 0 | 0.0000 | Novel Ruthenacarborane-NSAID Conjugates | Sonam S, Mojic M, Gordic V, Laube M, Schädlich J, Pietzsch J, Nicoara A, Gaina L, Mijatovic S, Maksimovic-Ivanic D, Kaluderovic G, Hey-Hawkins E | 44. | AP899 | 2026 | E | MEDICAL HYPOTHESES Vol. 206 (): #111844 - (4), (DOI: 10.1016/j.mehy.2025.111844) JAN 2026WOS | 0 | 0 | 7 | 0 | 0.0000 | Naturally aged rats, characterized by persulfidation decline, provide an adequate translational preclinical model for BPH: A hypothesis | Miler M, Mijajlovic V, Vukojevic M, Mojic M, Filipovic B, Zivanovic J, Ajdzanovic V |
|---|
27. 04. 2026.; 00:05:44; Trajanje procesiranja: 0.023 s
Legenda:
RB - redni broj rezultata
IBI - identifikacioni broj istraživača
Godina - godina u kojoj je rezultat publikovan (isključivo sa kompletnom paginacijom)
Kat - kategorija rezulata
Tip - tip rezultata (teorijski, simulacioni ili eksperimentalni)
Vrsta - vrsta rezultata
Referenca - referenca rezultata (bez autora i naslova rezultata) sa direktnim linkom na rezultat (ako ima DOI broj), sa linkom na zapis u eNauci ili WOS
TC - ukupan broj citata rezulata na dan 31. 1. 2026. godine
TCP - ukupan broj citata rezultata u periodu 2015-2024
BA - broj autora na rezultatu
NBB - normirani broj bodova rezultata
NTC - normirani broj citata rezultata u periodu 2015-2024
Naslov - naslov rezultata
Autori - spisak svih autora ili najviše prvih 30 autora
Primer:
Primer normiranja broja M poena i broja citata ostvarenih na jednom rezultatu: eksperimentalni rad sa 11 autora u časopisu kategorije M21a+ koji je publikovan 2020. godine, citiran je 65 puta, od čega 55 puta u periodu 2015-2024. godine.
Normirani broj M poena koje istraživač ostvaruje na rezultatu je 20/(1+0.2*(11-10))=16.6667 a normirani broj citata je 55/(1+0.2*(11-10))=45.8333.
Ukupan broj ostaverinih bodova utvrđuje se na naznačenom periodu za sabiranje normiranih M poena svakog istraživača i u periodu za određivanje ukupnog broja normiranih citata (2015-2024).